Results 1 to 10 of about 16,224 (212)

Genetics of Progressive Supranuclear Palsy [PDF]

open access: yesJournal of Movement Disorders, 2015
Progressive supranuclear palsy (PSP) is a neurodegenerative syndrome that is clinically characterized by progressive postural instability, supranuclear gaze palsy, parkinsonism and cognitive decline.
Sun Young Im   +2 more
doaj   +3 more sources

Clinical Features of Patients With Progressive Supranuclear Palsy in an US Insurance Claims Database

open access: yesFrontiers in Neurology, 2021
Background: Progressive supranuclear palsy is a rare neurodegenerative movement disorder and little is known about its epidemiology.Objective: Estimate age-adjusted prevalence of progressive supranuclear palsy and describe antecedent diagnoses and ...
Emma Viscidi   +11 more
doaj   +1 more source

Umbilical cord blood stem cells transplantation in a patient with severe progressive supranuclear palsy: a case report

open access: yesJournal of Medical Case Reports, 2021
Background Progressive supranuclear palsy is a neurodegenerative condition that worsens over time. Given the lack of targeted treatments, patients with severe progressive supranuclear palsy have very low life expectancy.
Huiping Li   +7 more
doaj   +1 more source

Neuroimaging correlates of gait abnormalities in progressive supranuclear palsy

open access: yesNeuroImage: Clinical, 2021
Progressive supranuclear palsy is a neurodegenerative disorder characterized primarily by tau inclusions and neurodegeneration in the midbrain, basal ganglia, thalamus, premotor and frontal cortex.
Irene Sintini   +12 more
doaj   +1 more source

The Significance of Asymmetry in the Assessment of Brain Perfusion in Atypical Tauopathic Parkinsonian Syndromes

open access: yesDiagnostics, 2022
Progressive supranuclear palsy syndrome (PSPS) and corticobasal syndrome (CBS) are clinical manifestations of tauopathic Parkinsonian syndromes. Due to their overlapping symptomatology, the differential diagnosis of these entities may be difficult when ...
Piotr Alster   +6 more
doaj   +1 more source

9.4 T MR microscopy of the substantia nigra with pathological validation in controls and disease

open access: yesNeuroImage: Clinical, 2017
Background: The anatomy of the substantia nigra on conventional MRI is controversial. Even using histological techniques it is difficult to delineate with certainty from surrounding structures.
LA Massey   +12 more
doaj   +1 more source

Plasma metabolite biomarkers for multiple system atrophy and progressive supranuclear palsy.

open access: yesPLoS ONE, 2019
Radiological biomarkers have been reported for multiple system atrophy and progressive supranuclear palsy, but serum/plasma biomarkers for each disorder have not been established.
Akio Mori   +10 more
doaj   +1 more source

A longitudinal study of motor, oculomotor and cognitive function in progressive supranuclear palsy.

open access: yesPLoS ONE, 2013
ObjectiveWe studied the annual change in measures of motor, oculomotor and cognitive function in progressive supranuclear palsy. This had twin objectives, to assess the potential for clinical parameters to monitor disease progression in clinical trials ...
Boyd C P Ghosh   +2 more
doaj   +1 more source

Comparison of gait in progressive supranuclear palsy, Parkinson’s disease and healthy older adults

open access: yesBMC Neurology, 2012
Background Progressive supranuclear palsy and Parkinson’s disease have characteristic clinical and neuropathologic profiles, but also share overlapping clinical features. This study aimed to analyze the gait of people with progressive supranuclear palsy (
Egerton Thorlene   +2 more
doaj   +1 more source

Clinical features of progressive supranuclear palsy

open access: yesFrontiers in Aging Neuroscience, 2023
BackgroundProgressive supranuclear palsy (PSP) is a clinically heterogenous atypical parkinsonian syndrome. Therefore, early recognition and correct diagnosis of PSP is challenging but essential.
Yafei Wen   +36 more
doaj   +1 more source

Home - About - Disclaimer - Privacy